"10.1371_journal.pone.0097011","plos one","2014-05-09T00:00:00Z","Willard Tinago; Elizabeth Coghlan; Alan Macken; Julie McAndrews; Brenda Doak; Charlotte Prior-Fuller; John S Lambert; Gerard J Sheehan; Patrick W G Mallon; on behalf of the Mater Immunology Study Group","HIV Molecular Research Group, School of Medicine and Medical Science, University College Dublin, Dublin, Ireland; Department of Community Medicine, University of Zimbabwe, Harare, Zimbabwe; Department of Immunology, Mater Misericordiae University Hospital, Dublin, Ireland; Department of Infectious Diseases, Mater Misericordiae University Hospital, Dublin, Ireland","Conceived and designed the experiments: WT PWGM. Performed the experiments: JM BD JSL CPF GJS PWGM EC. Analyzed the data: WT AM PWGM. Contributed reagents/materials/analysis tools: JM BD CPF WT AM EC. Wrote the paper: WT PWGM AM. Involved in the acquisition of patient clinical data: EC JSL GJS PWGM.","This work was supported by an unrestricted fund from GlaxoSmithKline. http://www.gsk.ie/gsk_at_a_glance/glaxosmithkline_dublin.html. PWGM's institution has received research grants and lectureship sponsorship from GlaxoSmithKline. There are no patents products in development or marked products to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","05","Willard Tinago","WT",10,TRUE,2,7,3,3,TRUE,TRUE,TRUE,1,"10",TRUE
